P3 Health Partners Inc.
PIII
$6.35
-$0.07-1.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.49B | 1.50B | 1.48B | 1.40B | 1.35B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.49B | 1.50B | 1.48B | 1.40B | 1.35B |
| Cost of Revenue | 1.55B | 1.56B | 1.52B | 1.39B | 1.33B |
| Gross Profit | -64.17M | -58.92M | -40.20M | 8.73M | 21.56M |
| SG&A Expenses | 117.58M | 120.13M | 113.45M | 113.62M | 114.67M |
| Depreciation & Amortization | 85.57M | 86.06M | 86.54M | 86.59M | 86.67M |
| Other Operating Expenses | 45.74M | 53.70M | 12.43M | -18.23M | -16.85M |
| Total Operating Expenses | 1.80B | 1.82B | 1.73B | 1.58B | 1.52B |
| Operating Income | -313.06M | -318.80M | -252.62M | -173.25M | -162.94M |
| Income Before Tax | -301.63M | -305.99M | -249.14M | -179.56M | -179.11M |
| Income Tax Expenses | 3.39M | 4.39M | 1.20M | 5.22M | 4.48M |
| Earnings from Continuing Operations | -305.02 | -310.38 | -250.34 | -184.78 | -183.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 167.39M | 174.53M | 147.64M | 115.30M | 116.31M |
| Net Income | -137.63M | -135.85M | -102.69M | -69.48M | -67.27M |
| EBIT | -313.06M | -318.80M | -252.62M | -173.25M | -162.94M |
| EBITDA | -227.49M | -232.74M | -166.08M | -86.66M | -76.27M |
| EPS Basic | -50.19 | -51.77 | -37.67 | -29.13 | -29.29 |
| Normalized Basic EPS | -10.00 | -8.51 | -3.40 | 1.36 | 1.90 |
| EPS Diluted | -58.39 | -59.98 | -60.90 | -51.17 | -48.36 |
| Normalized Diluted EPS | -9.92 | -8.43 | -3.31 | 1.11 | 1.64 |
| Average Basic Shares Outstanding | 11.56M | 10.68M | 10.65M | 9.70M | 9.12M |
| Average Diluted Shares Outstanding | 11.71M | 10.83M | 10.80M | 13.76M | 13.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |